Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

21 results
Display

Texture Analysis of Three-Dimensional MRI Images May Differentiate Borderline and Malignant Epithelial Ovarian Tumors

Ye R, Weng S, Li Y, Yan C, Chen J, Zhu Y, Wen L

Objective: To explore the value of magnetic resonance imaging (MRI)-based whole tumor texture analysis in differentiating borderline epithelial ovarian tumors (BEOTs) from FIGO stage I/II malignant epithelial ovarian tumors (MEOTs). Materials...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Assessment of solid components of borderline ovarian tumor and stage I carcinoma: added value of combined diffusion- and perfusion-weighted magnetic resonance imaging

Kim SH

BACKGROUND: We sought to determine the value of combining diffusion-weighted (DW) and perfusion-weighted (PW) sequences with a conventional magnetic resonance (MR) sequence to assess solid components of borderline ovarian tumors...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Clinical Practice at a Single Hospital in Korea

Park H, Shin JE, Lee DW, Kim MJ, Lee HN

BACKGROUND: The risk of ovarian malignancy algorithm (ROMA) is used for assessing ovarian cancer risk in women with a pelvic mass. Its diagnostic accuracy is variable. We investigated whether the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Oncologic and obstetric outcomes of conservative surgery for borderline ovarian tumors in women of reproductive age

Lee SY, Choi MC, Kwon BR, Jung SG, Park H, Joo WD, Lee C, Lee JH, Lee JM

OBJECTIVE: To compare the oncologic and obstetric outcomes in reproductive-age females with borderline ovarian tumors (BOTs) treated with cyst enucleation (CE) or unilateral salpingo-oophorectomy (USO). METHODS: The medical records of patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Controversies in borderline ovarian tumors

Seong SJ, Kim DH, Kim MK, Song T

Borderline ovarian tumors (BOTs) represent about 15% to 20% of all ovarian malignancies and differ from invasive ovarian cancers (IOCs) by many characters. Historically, standard management of BOT is peritoneal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Epithelial borderline ovarian tumor: Diagnosis and treatment strategy

Ushijima K, Kawano K, Tsuda N, Nishio S, Terada A, Kato H, Tasaki K, Matsukuma

Epithelial borderline ovarian tumors (BOT) are distinctive from benign tumors and carcinoma. They occur in younger women more often than carcinoma, and there is some difficulty making correct diagnosis of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Differential Diagnosis of Borderline Ovarian Tumors from Stage I Malignant Ovarian Tumors using FDG PET/CT

Kim C, Chung HH, Oh SW, Kang KW, Chung JK, Lee DS

  • KMID: 1427687
  • Nucl Med Mol Imaging.
  • 2013 Jun;47(2):81-88.
PURPOSE: Borderline ovarian tumors (BOTs) are more common in young women of reproductive age, and exhibit a better prognosis than malignant ovarian tumors (MOTs). Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Survival of women with ovarian carcinomas and borderline tumors is not affected by estrogen and progesterone receptor status

Sallum LF, Sarian LO, Lucci De Angelo Andrade L, Vassallo J, Soares FA, Pinto GA, Ferreira P, Derchain S

OBJECTIVE: To examine the patterns of estrogen receptor (ER) and progesterone receptor (PR) expression in borderline ovarian tumors (BOTs) and ovarian carcinomas. We also assessed the disease-free survival (DFS) and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Histologic distribution of borderline ovarian tumors worldwide: a systematic review

Song T, Lee YY, Choi CH, Kim TJ, Lee JW, Bae DS, Kim BG

OBJECTIVE: The histologic types of borderline ovarian tumors (BOTs) exhibit striking differences in clinical behavior and prognosis. Yet, there is no information available on the histologic distribution of BOTs according...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Serum CA-125 Concentration Data Assists in Evaluating CT Imaging Information When Used to Differentiate Borderline Ovarian Tumor from Malignant Epithelial Ovarian Tumors

Shin JE, Choi HJ, Kim MH, Cho KS

OBJECTIVE: We wanted to evaluate the diagnostic value of serum CA-125 concentration, when used in combination with the preoperative contrast-enhanced CT results, to differentiate borderline ovarian tumors (BOTs) from stage...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Single-port access laparoscopic staging operation for a borderline ovarian tumor

Yoon A, Kim TJ, Lee WS, Kim BG, Bae DS

Minimally invasive surgery is widely used in benign gynecologic diseases and may be used in malignancies. We performed a single-port access laparoscopy staging - bilateral salpingo-oophorectomy, laparoscopy-assisted vaginal hysterectomy, bilateral...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current management of borderline ovarian tumor

Lee SY, Ju W

  • KMID: 2273757
  • Korean J Obstet Gynecol.
  • 2009 Sep;52(9):895-902.
The mainstream in management of borderline ovarian tumor has been thorough surgical staging and close observation. Recent trends prefer conservative management especially for the young, reproductive aged women due to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Laparoscopic management of borderline ovarian tumors; KBSMC experience

Jung US, Lee JH, Kyung MS, Lee KW, Han JS, Choi JS

  • KMID: 2273243
  • Korean J Obstet Gynecol.
  • 2008 Feb;51(2):182-190.
OBJECTIVE: To evaluate feasibility and efficacy of laparoscopic management for borderline ovarian tumors. METHODS: From May 2005 to October 2007 in our institution, laparoscopic treatments were performed for 16 patients for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Outcomes of Controlled Ovarian Hyperstimulation/In Vitro Fertilization for Infertile Patients with Borderline Ovarian Tumor after Conservative Treatment

Park CW, Yang KM, Kim HO, Hong SR, Kim TJ, Lim KT, Lee KH, Kang IS

To evaluate the outcomes of controlled ovarian hyperstimulation (COH)-in vitro fertilization (IVF) such as clinical pregnancy rate (CPR), implantation rate (IR) and live birth rate (LBR) for infertile patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A clinical study of borderline malignant tumors of the ovary

Jeong NH, Kim YA, Jeong SG, Lee C, Kim T, Kim HJ, Lee KW, Lee NW

  • KMID: 2244575
  • Korean J Gynecol Oncol.
  • 2007 Mar;18(1):39-47.
OBJECTIVE: The purpose of this study was to evaluate the clinical and histopathological features, and to find relationship between treatment modality and prognosis of borderline ovarian tumors. METHODS: Ninety-three cases...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical significance of surgical staging and lymphadenectomy in patients with borderline ovarian tumors

Chang SJ, Ji YI, Yoon J, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH, Mok JE

  • KMID: 2143529
  • Korean J Gynecol Oncol.
  • 2006 Mar;17(1):68-73.
OBJECTIVE: To compare the outcome of patients with borderline ovarian tumors who had been surgically staged with those who were not staged. METHODS: Between 1997 and 2004, there were 204 patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Primary Mixed Carcinoid Tumor and Mucinous Tumor of Borderline Malignancy of the Ovary

Lee SY, Ha MT, Jeong MS, Shin JK, Choi WJ, Park JK, Lee JH, Paik WY

  • KMID: 2272810
  • Korean J Obstet Gynecol.
  • 2006 Feb;49(2):466-471.
Primary mixed carcinoid with mucinous tumor of borderline malignancy of the ovary is very rare ovarian tumor. Most of them arose in dermoid cyst or in mature solid teratoma. Its...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A clinical study of borderline ovarian tumor: The significance of microinvasion

Lee KB, Lee JM, Park CY, Cho HY

  • KMID: 1575038
  • Korean J Gynecol Oncol.
  • 2005 Sep;16(3):189-194.
OBJECTIVE: To identify the clinical features, survival rate, and prognostic factors of the borderline ovarian tumor. METHODS: Data on 48 patients with borderline ovarian tumor were analyzed with regard to histologic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Clinical Study of Borderline Malignant Tumors of the Ovary

Lee JH, Kim JJ, Sin CS, Park JS, Han KS, Bae KH

  • KMID: 2020110
  • Korean J Obstet Gynecol.
  • 2003 Jan;46(1):22-27.
OBJECTIVE: To evaluate the clinical and histopathological features, treatment and prognosis of borderline ovarian tumors (BOT). METHODS: Thirty nine cases of BOT were treated between January 1985 and December 2001 at...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Study of Borderline Ovarian Malignancy

Lee SH, Bae TW, Lee NJ, Kim CJ, Park TC, Lee JM, Namkoong S

  • KMID: 2262670
  • Korean J Obstet Gynecol.
  • 2002 Mar;45(3):470-474.
OBJECTIVES: The purpose of this study is to investigate the clinicopathologic characteristics and the risk factors affecting the recurrence in patients with borderline ovarian malignancy. METHODS: From January 1996 to January...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr